Search Results

There are 18659 results for: content related to: Phenotype of entero-endocrine L cells becomes restricted during development

  1. Mechanisms for the cardiovascular effects of glucagon-like peptide-1

    Acta Physiologica

    Volume 216, Issue 3, March 2016, Pages: 277–313, H. Poudyal

    Version of Record online : 8 OCT 2015, DOI: 10.1111/apha.12604

  2. You have free access to this content
    GLP-1R and amylin agonism in metabolic disease: complementary mechanisms and future opportunities

    British Journal of Pharmacology

    Volume 166, Issue 1, May 2012, Pages: 121–136, Jonathan D Roth, Mary R Erickson, Steve Chen and David G Parkes

    Version of Record online : 10 APR 2012, DOI: 10.1111/j.1476-5381.2011.01537.x

  3. Poly-GLP-1, a novel long-lasting glucagon-like peptide-1 polymer, ameliorates hyperglycaemia by improving insulin sensitivity and increasing pancreatic beta-cell proliferation

    Diabetes, Obesity and Metabolism

    Volume 11, Issue 10, October 2009, Pages: 953–965, X. Ma, H. Hui, Z. Liu, G. He, J. Hu, J. Meng, L. Guan and X. Luo

    Version of Record online : 16 JUN 2009, DOI: 10.1111/j.1463-1326.2009.01070.x

  4. You have full text access to this Open Access content
    GIP and GLP-1, the two incretin hormones: Similarities and differences

    Journal of Diabetes Investigation

    Volume 1, Issue 1-2, February/April 2010, Pages: 8–23, Yutaka Seino, Mitsuo Fukushima and Daisuke Yabe

    Version of Record online : 22 APR 2010, DOI: 10.1111/j.2040-1124.2010.00022.x

  5. You have free access to this content
    Foetal proglucagon processing in relation to adult appetite control: lessons from a transplantable rat glucagonoma with severe anorexia

    Diabetes, Obesity and Metabolism

    Volume 13, Issue s1, October 2011, Pages: 60–68, P. B. Jensen, P. J. Larsen, C. Karlsen, H. I. Jensen, J. J. Holst and O. D. Madsen

    Version of Record online : 8 AUG 2011, DOI: 10.1111/j.1463-1326.2011.01439.x

  6. The role of glucagon-like peptide-1 impairment in obesity and potential therapeutic implications

    Diabetes, Obesity and Metabolism

    Volume 16, Issue 1, January 2014, Pages: 9–21, S. Madsbad

    Version of Record online : 26 MAY 2013, DOI: 10.1111/dom.12119

  7. Glucagon-like peptide-1 in the rat brain: Distribution of expression and functional implication

    Journal of Comparative Neurology

    Volume 521, Issue 10, 1 July 2013, Pages: 2235–2261, Guibao Gu, Barbara Roland, Kevin Tomaselli, Carrie S. Dolman, Carolyn Lowe and Joseph S. Heilig

    Version of Record online : 19 APR 2013, DOI: 10.1002/cne.23282

  8. You have free access to this content
    The structure and function of the glucagon-like peptide-1 receptor and its ligands

    British Journal of Pharmacology

    Volume 166, Issue 1, May 2012, Pages: 27–41, Dan Donnelly

    Version of Record online : 10 APR 2012, DOI: 10.1111/j.1476-5381.2011.01687.x

  9. You have free access to this content
    Review article: a comparison of glucagon-like peptides 1 and 2

    Alimentary Pharmacology & Therapeutics

    Volume 37, Issue 1, January 2013, Pages: 18–36, P. Janssen, A. Rotondo, F. Mulé and J. Tack

    Version of Record online : 5 NOV 2012, DOI: 10.1111/apt.12092

  10. You have free access to this content
    Emerging cardiovascular actions of the incretin hormone glucagon-like peptide-1: potential therapeutic benefits beyond glycaemic control?

    British Journal of Pharmacology

    Volume 157, Issue 8, August 2009, Pages: 1340–1351, David J Grieve, Roslyn S Cassidy and Brian D Green

    Version of Record online : 29 JUL 2009, DOI: 10.1111/j.1476-5381.2009.00376.x

  11. Glucagon and Glucagon-like Peptide Production and Degradation

    Standard Article

    Comprehensive Physiology

    Timothy J. Kieffer, Mehboob A. Hussain and Joel F. Habener

    Published Online : 1 JAN 2011, DOI: 10.1002/cphy.cp070208

  12. Structure and function studies of glucagon-like peptide-1 (GLP-1): the designing of a novel pharmacological agent for the treatment of diabetes

    Diabetes/Metabolism Research and Reviews

    Volume 21, Issue 4, July/August 2005, Pages: 313–331, Hongxiang Hui, Xiaoning Zhao and Riccardo Perfetti

    Version of Record online : 26 APR 2005, DOI: 10.1002/dmrr.553

  13. You have free access to this content
    Effect of Chronic Central Administration of Glucagon-Like Peptide-1 (7–36) Amide on Food Consumption and Body Weight in Normal and Obese Rats

    Obesity Research

    Volume 6, Issue 2, March 1998, Pages: 147–156, Jr. Harry R. Davis, Deborra E. Mullins, Jesse M. Pines, Lizbeth M. Hoos, Constance F. France, Douglas S. Compton, Michael P. Graziano, Edmund J. Sybertz, Catherine D. Strader and Margaret Van Heek

    Version of Record online : 6 SEP 2012, DOI: 10.1002/j.1550-8528.1998.tb00329.x

  14. Glucagon-like peptide 1(GLP-1) in biology and pathology

    Diabetes/Metabolism Research and Reviews

    Volume 21, Issue 2, March/April 2005, Pages: 91–117, Juris J. Meier and Michael A. Nauck

    Version of Record online : 9 MAR 2005, DOI: 10.1002/dmrr.538

  15. Islet Amyloid Polypeptide/GLP-1/Exendin

    Standard Article

    International Textbook of Diabetes Mellitus

    Laurie L. Baggio and Daniel J. Drucker

    Published Online : 1 JUL 2003, DOI: 10.1002/0470862092.d0209

  16. You have full text access to this Open Access content
    Comparison of incretin immunoassays with or without plasma extraction: Incretin secretion in Japanese patients with type 2 diabetes

    Journal of Diabetes Investigation

    Volume 3, Issue 1, February 2012, Pages: 70–79, Daisuke Yabe, Koin Watanabe, Kenji Sugawara, Hitoshi Kuwata, Yuka Kitamoto, Kazu Sugizaki, Shuichi Fujiwara, Masahiro Hishizawa, Takanori Hyo, Kyoko Kuwabara, Kayo Yokota, Masahiro Iwasaki, Naomi Kitatani, Takeshi Kurose, Nobuya Inagaki and Yutaka Seino

    Version of Record online : 4 JUL 2011, DOI: 10.1111/j.2040-1124.2011.00141.x

  17. You have free access to this content
    Differential effects of glucagon-like peptide-1 on microvascular recruitment and glucose metabolism in short- and long-term insulin resistance

    The Journal of Physiology

    Volume 593, Issue 9, 1 May 2015, Pages: 2185–2198, Kim A. Sjøberg, Stephen Rattigan, Jacob F. Jeppesen, Anne-Marie Lundsgaard, Jens J. Holst and Bente Kiens

    Version of Record online : 19 MAR 2015, DOI: 10.1113/JP270129

  18. You have free access to this content
    Molecular mechanisms underlying physiological and receptor pleiotropic effects mediated by GLP-1R activation

    British Journal of Pharmacology

    Volume 171, Issue 5, March 2014, Pages: 1114–1128, K Pabreja, M A Mohd, C Koole, D Wootten and S G B Furness

    Version of Record online : 27 FEB 2014, DOI: 10.1111/bph.12313

  19. Glucagon-like peptide-1 (GLP-1): A gut hormone of potential interest in the treatment of diabetes

    BioEssays

    Volume 20, Issue 8, August 1998, Pages: 642–651, Bo Ahrén

    Version of Record online : 7 DEC 1998, DOI: 10.1002/(SICI)1521-1878(199808)20:8<642::AID-BIES7>3.0.CO;2-K

  20. You have free access to this content
    The future of incretin-based therapy: novel avenues—novel targets

    Diabetes, Obesity and Metabolism

    Volume 13, Issue s1, October 2011, Pages: 158–166, B. Ahrén

    Version of Record online : 8 AUG 2011, DOI: 10.1111/j.1463-1326.2011.01457.x